MTOR and nonpapillary renal cell carcinoma: Here, we demonstrated that the attenuation of ALDH9A1 in ccRCC triggers aberrant abnormal activation of the AKT-mTOR pathway, which is responsible for the tumor progression and lipid accumulation mediated by SREBP1.